Exploring the link between cardiovascular risk factors and manifestations in latent tuberculosis infection: a comprehensive literature review
Tóm tắt
The global burden of tuberculosis (TB) and cardiovascular disease (CVD) is overt, and the prevalence of this double burden disease remains steadily rising, particularly in low- and middle-income countries. This review aims to explore the association between latent tuberculosis infection (LTBI) and the development of cardiovascular diseases and risk factors. Furthermore, we elucidated the underlying pathophysiological mechanisms that contribute to this relationship.
Approximately 25% of the global population carries a dormant form of tuberculosis (TB) infection. During this latent stage, certain subsets of mycobacteria actively reproduce, and recent research suggests that latent TB infection (LTBI) is connected to persistent, long-term low-grade inflammation that can potentially contribute to the development of atherosclerosis and cardiovascular disease (CVD). The presence of LTBI can be confirmed through a positive result on either a tuberculin skin test (TST) or an interferon-gamma release assay (IGRA). Several plausible explanations for the association between LTBI and CVD include increased inflammation, autoimmunity related to heat shock proteins (HSP), and the presence of pathogens within the developing atherosclerotic plaque. The most commonly observed cardiovascular events and risk factors associated with LTBI are acute myocardial infarction, coronary artery stenosis, diabetes mellitus, and hypertension.
This article highlights the critical role of LTBI in perpetuating the tuberculosis disease cycle and its association with cardiovascular risk factors. Chronic and persistent low inflammation underlined the association. Identifying high-risk LTBI patients and providing targeted preventive medication are crucial strategies for global TB eradication and interrupting transmission chains.
Từ khóa
Tài liệu tham khảo
Houben RMGJ, Dodd PJ (2016) The global burden of latent tuberculosis infection: A re-estimation using. Mathematical Modelling. https://doi.org/10.1371/journal.pmed.1002152
WHO. TB burden report 2018. vol. 63. 2018.
Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N et al (2018) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 392:1736–1788. https://doi.org/10.1016/S0140-6736(18)32203-7
Chung WS, Lin CL, Hung CT, Chu YH, Sung FC, Kao CH et al (2014) Tuberculosis increases the subsequent risk of acute coronary syndrome: A nationwide population-based cohort study. International Journal of Tuberculosis and Lung Disease 18:79–83. https://doi.org/10.5588/ijtld.13.0288
Wang SH, Chien WC, Chung CH, Lin FH, Peng CK, Chian CF et al (2017) Tuberculosis increases the risk of peripheral arterial disease: A nationwide population-based study. Respirology 22:1670–1676. https://doi.org/10.1111/resp.13117
Huaman MA, Henson D, Ticona E, Sterling TR, Garvy BA (2015) Tuberculosis and Cardiovascular Disease: Linking the Epidemics. Trop Dis Travel Med Vaccines. https://doi.org/10.1186/s40794-015-0014-5
Sheu JJ, Chiou HY, Kang JH, Chen YH, Lin HC (2010) Tuberculosis and the risk of ischemic stroke: A 3-year follow-up study. Stroke 41:244–249. https://doi.org/10.1161/STROKEAHA.109.567735
Romanowski K, Baumann B, Basham CA, Ahmad Khan F, Fox GJ, Johnston JC (2019) Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 19:1129–1137. https://doi.org/10.1016/S1473-3099(19)30309-3
Basham CA, Smit SJ, Romanowski K, Johnsto JC (2020) Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis. PLoS ONE 15:1–19. https://doi.org/10.1371/journal.pone.0235821
Barry CE 3rd, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J et al (2009) The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 7:845–855. https://doi.org/10.1038/nrmicro2236
Drain PK, Bajema KL, Dowdy D, Dheda K, Naidoo K, Schumacher SG et al (2018) Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection. Clin Microbiol Rev. https://doi.org/10.1128/CMR.00021-18
Dutta NK, Karakousis PC (2014) Latent tuberculosis infection: myths, models, and molecular mechanisms. Microbiol Mol Biol Rev 78:343–371. https://doi.org/10.1128/MMBR.00010-14
Wergeland I, Assmus J, Dyrhol-Riise AM (2011) T regulatory cells and immune activation in Mycobacterium tuberculosis infection and the effect of preventive therapy. Scand J Immunol 73:234–242. https://doi.org/10.1111/j.1365-3083.2010.02496.x
Sullivan ZA, Wong EB, Ndung’u T, Kasprowicz VO, Bishai WR (2015) Latent and ‘h HIV. EBioMedicine 2:334–340. https://doi.org/10.1016/j.ebiom.2015.03.005
Pothineni NVK, Subramany S, Kuriakose K, Shirazi LF, Romeo F, Shah PK et al (2017) Infections, atherosclerosis, and coronary heart disease. Eur Heart J 38:3195–3201. https://doi.org/10.1093/eurheartj/ehx362
Salgame P, Geadas C, Collins L, Jones-López E, Ellner JJ (2015) Latent tuberculosis infection - Revisiting and revising concepts. Tuberculosis 95:373–384. https://doi.org/10.1016/j.tube.2015.04.003
Getahun H, Matteelli A, Chaisson RE, Raviglione M (2015) Latent Mycobacterium tuberculosis infection. N Engl J Med 372:2127–2135. https://doi.org/10.1056/NEJMra1405427
Organization WH. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva PP - Geneva: World Health Organization; n.d.
Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC et al (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163:1009–1021. https://doi.org/10.1001/archinte.163.9.1009
Chee CB-E, Sester M, Zhang W, Lange C (2013) Diagnosis and treatment of latent infection with Mycobacterium tuberculosis. Respirology 18:205–216. https://doi.org/10.1111/resp.12002
Khoufi EA (2021) Association between latent tuberculosis and ischemic heart disease: a hospital-based cross-sectional study from Saudi Arabia. Pan Afr Med J 38:362. https://doi.org/10.11604/pamj.2021.38.362.28110
Gideon HP, Phuah J, Myers AJ, Bryson BD, Rodgers MA, Coleman MT et al (2015) Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization. PLoS Pathog 11:e1004603. https://doi.org/10.1371/journal.ppat.1004603
Dannenberg AMJ (1994) Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis. Immunobiology 191:461–473. https://doi.org/10.1016/S0171-2985(11)80452-3
Riley RL (1957) Aerial dissemination of pulmonary tuberculosis. Am Rev Tuberc 76:931–941. https://doi.org/10.1164/artpd.1957.76.6.931
Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D et al (2009) LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 33:956–973. https://doi.org/10.1183/09031936.00120908
Grzybowski S, Barnett GD, Styblo K (1975) Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc 50:90–106
Jones-López EC, Kim S, Fregona G, Marques-Rodrigues P, Hadad DJ, Molina LPD et al (2014) Importance of cough and M. tuberculosis strain type as risks for increased transmission within households. PLoS ONE 10:10–15. https://doi.org/10.1371/journal.pone.0100984
Huaman MA, Ticona E, Miranda G, Kryscio RJ, Mugruza R, Aranda E et al (2018) The relationship between latent tuberculosis infection and acute myocardial infarction. Clin Infect Dis 66:886–892. https://doi.org/10.1093/cid/cix910
Epstein SE, Zhu J, Najafi AH, Burnett MS (2009) Insights into the role of infection in atherogenesis and in plaque rupture. Circulation 119:3133–3141. https://doi.org/10.1161/CIRCULATIONAHA.109.849455
Gill WP, Harik NS, Whiddon MR, Liao RP, Mittler JE, Sherman DR (2009) A replication clock for Mycobacterium tuberculosis. Nat Med 15:211–214. https://doi.org/10.1038/nm.1915
Huaman MA, de Cecco CN, Bittencourt MS, Ticona E, Kityo C, Ballena I et al (2021) Latent tuberculosis infection and subclinical coronary atherosclerosis in Peru and Uganda. Clin Infect Dis 73:E3384–E3390. https://doi.org/10.1093/cid/ciaa1934
Huaman MA, Deepe GSJ, Fichtenbaum CJ (2016) Elevated circulating concentrations of interferon-gamma in latent tuberculosis infection. Pathog Immun 1:291–303. https://doi.org/10.20411/pai.v1i2.149
Cowan J, Pandey S, Filion LG, Angel JB, Kumar A, Cameron DW (2012) Comparison of interferon-γ-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection. Clin Exp Immunol 167:317–329. https://doi.org/10.1111/j.1365-2249.2011.04520.x
Alsayed-Hasanain AF, El-Maghraby KM, Zayed AA, Nafee AM, Abdel-Aal SM, Bakkar SM (2018) Latent tuberculosis infection among patients with coronary artery stenosis: a case-control study. Int J Mycobacteriol 7:143–147. https://doi.org/10.4103/ijmy.ijmy_34_18
Erdenebat D. Latent Tuberculosis Infection and Dyslipidemia among Refugees Attending a Community Based Clinic in Georgia. 2018.
Magee MJ, Khakharia A, Gandhi NR, Day CL, Kornfeld H, Rhee MK et al (2022) Increased risk of incident diabetes among individuals with latent tuberculosis infection. Diabetes Care 45:880–887. https://doi.org/10.2337/dc21-1687